Circulation · 2023 · 28 citations · 38 references
cMLCK dysregulation contributes to the development of cardiac systolic dysfunction in humans. Our strategy to restore cMLCK activity could form the basis of a novel myotropic therapy for advanced systolic heart failure.
38
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · New England Journal of Medicine · 2020 · 625 citations · Full text
ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes
Kazuto Yoshimi, Yayoi Kunihiro, Takehito Kaneko et al. · Nature Communications · 2016 · 353 citations · Full text